相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model
Hong Pu et al.
CANCER RESEARCH (2009)
HIF-1α and HIF-2α Are Differentially Regulated In vivo in Neuroblastoma: High HIF-1α Correlates Negatively to Advanced Clinical Stage and Tumor Vascularization
Rosa Noguera et al.
CLINICAL CANCER RESEARCH (2009)
Role of the VEGFR3/VEGFD Receptor Axis in TGFβ1 Activation of Primary Prostate Cell Lines
S. M. Goodyear et al.
PROSTATE (2009)
Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer
Karolina Helczynska et al.
CANCER RESEARCH (2008)
NF-κB Activates Transcription of the RNA-Binding Factor HuR, via PI3K-AKT Signaling, to Promote Gastric Tumorigenesis
Min-Ju Kang et al.
GASTROENTEROLOGY (2008)
High levels of HIF-2α highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche
A. Pietras et al.
JOURNAL OF PATHOLOGY (2008)
mRNA stability and cancer: an emerging link?
Don Benjamin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice
Shan Lu et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms underlying TGF-β1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis
Seong-Hyun Jeon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype
Linda Holmquist-Mengelbier et al.
CANCER CELL (2006)
Transforming growth factor β1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression
Stephanie McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer
JL Boddy et al.
CLINICAL CANCER RESEARCH (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Transcriptional regulation of vascular endothelial growth factor in cancer
RMB Loureiro et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1α and HIF-2α expression in lung epithelial cells -: Implication of natural antisense HIF-1α
T Uchida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transforming growth factor-β1 stimulates vascular endothelial growth factor 164 via mitogen-activated protein kinase kinase 3-p38α and p38δ mitogen-activated protein kinase-dependent pathway in murine mesangial cells
L Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Prognostic impact of hypoxia-inducible factors 1α and 2α in colorectal cancer patients:: Correlation with tumor angiogenesis and cyclooxygenase-2 expression
H Yoshimura et al.
CLINICAL CANCER RESEARCH (2004)
Up-regulation of hypoxia-inducible factor 1 alpha is an early event in prostate carcinogenesis
H Zhong et al.
CANCER DETECTION AND PREVENTION (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2
H Tran et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
A Giatromanolaki et al.
MELANOMA RESEARCH (2003)
Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways
JI Park et al.
ONCOGENE (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Distortion of autocrine transforming growth factor β signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells
Y Sugano et al.
ONCOGENE (2003)
The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
JK Maranchie et al.
CANCER CELL (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells
DA Dixon et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression
T Sánchez-Elsner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence
WG Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation
WG Wang et al.
EMBO JOURNAL (2000)
分享论文
